Akamai CEO, Twilio CEO & Homework: MindMedicine

The Dow fell 94 points today and Jim Cramer’s highlighting some leaders in market. Then, Cramer‘s joined by Akamai’s CEO talking the rise of cyber attacks in the U.S. and how the 20 year old company plans to defend against them. Then, Twilio’s CEO discusses how they’re helping out in the vaccine front and how the business looks going forward. Plus, Cramer’s turning in his homework on MindMedicine, the company studying psychedelic drugs used as treatment for serious afflictions. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.